Blue Cross and Blue Shield of Illinois policy
Gene Therapies for Sickle Cell Disease
Gene Therapies for Sickle Cell Disease is a public Blue Cross and Blue Shield of Illinois policy (policy RX501.167, effective Sep 15, 2026). It lists 2 CPT or HCPCS codes. Not a coverage decision; the payer's own document governs.
View the original policy (PDF) ↗
- Policy number
- RX501.167
- Effective
- Sep 15, 2026
- Line of business
- Commercial, Medicaid
- Source
- medicalpolicy.hcsc.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes.
| Code | Other Blue Cross and Blue Shield of Illinois policies |
|---|---|
| J3392 | Policies naming J3392 |
| J3394 | Policies naming J3394 |